chr5-32395185-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_016107.5(ZFR):​c.1953A>G​(p.Glu651Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00342 in 1,605,684 control chromosomes in the GnomAD database, including 172 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 85 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 87 hom. )

Consequence

ZFR
NM_016107.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.221

Publications

2 publications found
Variant links:
Genes affected
ZFR (HGNC:17277): (zinc finger RNA binding protein) This gene encodes an RNA-binding protein characterized by its DZF (domain associated with zinc fingers) domain. The encoded protein may play a role in the nucleocytoplasmic shuttling of another RNA-binding protein, Staufen homolog 2, in neurons. Expression of this gene is regulated through alternative polyadenylation that mediates differential microRNA targeting. Elevated expression of this gene has been observed in human patients with pancreatic cancer and knockdown of this gene may result in reduced viability and invasion of pancreatic cancer cells. [provided by RefSeq, Sep 2016]
ZFR Gene-Disease associations (from GenCC):
  • autosomal recessive spastic paraplegia type 71
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 5-32395185-T-C is Benign according to our data. Variant chr5-32395185-T-C is described in ClinVar as Benign. ClinVar VariationId is 544264.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.221 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0639 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZFRNM_016107.5 linkc.1953A>G p.Glu651Glu synonymous_variant Exon 11 of 20 ENST00000265069.13 NP_057191.2 Q96KR1Q05D65
ZFRNR_144318.2 linkn.2035A>G non_coding_transcript_exon_variant Exon 11 of 19

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZFRENST00000265069.13 linkc.1953A>G p.Glu651Glu synonymous_variant Exon 11 of 20 1 NM_016107.5 ENSP00000265069.8 Q96KR1

Frequencies

GnomAD3 genomes
AF:
0.0187
AC:
2844
AN:
152192
Hom.:
85
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0658
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00537
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00475
AC:
1169
AN:
246204
AF XY:
0.00365
show subpopulations
Gnomad AFR exome
AF:
0.0675
Gnomad AMR exome
AF:
0.00218
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000623
Gnomad OTH exome
AF:
0.00117
GnomAD4 exome
AF:
0.00182
AC:
2638
AN:
1453374
Hom.:
87
Cov.:
31
AF XY:
0.00158
AC XY:
1140
AN XY:
723190
show subpopulations
African (AFR)
AF:
0.0669
AC:
2208
AN:
33016
American (AMR)
AF:
0.00259
AC:
112
AN:
43220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25956
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39256
South Asian (SAS)
AF:
0.000318
AC:
27
AN:
84972
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52982
Middle Eastern (MID)
AF:
0.00245
AC:
14
AN:
5720
European-Non Finnish (NFE)
AF:
0.0000271
AC:
30
AN:
1108394
Other (OTH)
AF:
0.00413
AC:
247
AN:
59858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
116
232
349
465
581
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0188
AC:
2857
AN:
152310
Hom.:
85
Cov.:
32
AF XY:
0.0184
AC XY:
1373
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0660
AC:
2741
AN:
41560
American (AMR)
AF:
0.00536
AC:
82
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68034
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
132
265
397
530
662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00995
Hom.:
22
Bravo
AF:
0.0210
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pure or complex autosomal recessive spastic paraplegia Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

ZFR-related disorder Benign:1
Nov 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
2.6
DANN
Benign
0.53
PhyloP100
-0.22
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
3.8
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77829878; hg19: chr5-32395291; COSMIC: COSV104370012; API